1. Home
  2. XNCR vs CHCO Comparison

XNCR vs CHCO Comparison

Compare XNCR & CHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$24.77

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo City Holding Company

CHCO

City Holding Company

N/A

Current Price

$141.39

Market Cap

2.1B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
XNCR
CHCO
Founded
1997
1957
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
XNCR
CHCO
Price
$24.77
$141.39
Analyst Decision
Buy
Hold
Analyst Count
14
5
Target Price
$31.42
★ $140.40
AVG Volume (30 Days)
★ 1.0M
79.3K
Earning Date
11-04-2026
10-21-2026
Dividend Yield
N/A
★ 2.50%
EPS Growth
★ 65.36
13.18
EPS
N/A
★ 4.55
Revenue
★ $125,576,000.00
N/A
Revenue This Year
$14.05
$4.29
Revenue Next Year
N/A
$3.11
P/E Ratio
★ N/A
$30.70
Revenue Growth
★ 13.65
N/A
52 Week Low
$10.38
$113.21
52 Week High
$30.61
$148.99

Technical Indicators

Market Signals
Indicator
XNCR
CHCO
Relative Strength Index (RSI) 51.52 34.05
Support Level $23.36 $120.03
Resistance Level $30.61 $147.26
Average True Range (ATR) 1.03 2.45
MACD -0.09 -0.50
Stochastic Oscillator 55.23 1.32

Price Performance

Historical Comparison
XNCR
CHCO

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

Share on Social Networks: